Associate Medical Director, Rare Disease - Friederichs Ataxia (US Medical Affairs)

Biogen•Cambridge, MA

2d•$183,000 - $252,000

About The Position

The Associate Medical Director, Rare Disease role is part of Biogen’s North American Medical Affairs organization and the US Rare Disease Medical Directors’ office team. Reporting to the Medical Director, the Associate Medical Director supports the development and implementation of the US Medical Strategy for Biogen’s Friedreich’s ataxia (FA) therapeutic area, aligned with global strategy. The role provides scientific and strategic oversight for external communications, partners with cross-functional and global medical colleagues, develops relationships with external stakeholders, and contributes to medical materials, advisory boards, congress activities, and data-generation initiatives.

Requirements

MD, PhD, PharmD, or comparable advanced degree.
At least 3 years of pharmaceutical industry experience; relevant clinical practice experience in Rare Disease may be considered as a substitute.

Nice To Haves

Prior experience in a headquarters-based Medical Affairs role and/or Field Medical role.
Clinical experience and subject matter expertise in the therapeutic area, especially Friedreich’s ataxia and/or Rare Disease.
Experience with medical launch and products at various stages of the lifecycle.
Strong working knowledge of US regulations relevant to Medical Affairs.
Demonstrated ability to lead and collaborate effectively with global, regional, and/or affiliate medical teams to align regional activities with global medical strategy and ensure their insights and needs are known and addressed.
Ability to manage projects and take initiative to solve complex and challenging problems.
Excellent written and oral communication skills, including presentation skills.

Responsibilities

Contribute to developing and executing the US Medical strategy and tactics for the Rare Disease FA asset, aligned with global strategy.
Serve as the Medical lead in the Promotional Review Committee (PRC) process, providing strategic input and scientific oversight to ensure external communications are compliant, accurate, and impactful.
Serve as a key US Medical contact for cross-functional partners, including US Field Medical, Global Medical, Clinical Development, Epidemiology, Pharmacovigilance, Commercial, and Market Access.
Collaborate with global, regional, and/or affiliate medical teams to align medical activities with global medical strategy and communicate US-based insights and needs to Global Medical.
Understand local business needs and provide insights to local commercial teams so their plans align with medical strategy.
Build and nurture relationships with external stakeholders, including KMEs, healthcare institutions, and advocacy groups in the FA therapeutic landscape.
Contribute as a content expert to developing or adapting medical materials in accordance with Medical and Commercial product review committee requirements, including presentations, training materials, medical briefs, and talking points for internal colleagues and external stakeholder engagements.
Drive execution of the Rare Disease medical strategy by organizing and facilitating Advisory Board meetings and contributing to congress deliverables and data-generation initiatives.

Benefits

Medical, dental, vision, and life insurance.
Fitness and wellness programs, including fitness reimbursement.
Short- and long-term disability insurance.
At least 15 days of paid vacation and additional end-of-year shutdown time off from December 26 through December 31.
Up to 12 company-paid holidays and 3 paid days off for Personal Significance.
80 hours of sick time per calendar year.
Paid maternity and parental leave.
401(k) program with company-matched contributions.
Employee stock purchase plan.
Tuition reimbursement of up to $10,000 per calendar year.
Employee Resource Groups participation.
Short-term and long-term incentives, including cash bonus and equity incentive opportunities, based on individual, business unit, and company performance.